L'intérêt à découvert pour First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF (ARCA:FTCE), Rapport sur les intérêts à découvert

First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF

Technology

Consumer Cyclical

Financial Services

Healthcare

Industrials

Consumer Defensive

Energy

Real Estate

Basic Materials

Utilities

Other

Communication Services

The Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the total return performance of the Index. The Fund will generally employ a full replication strategy, meaning that it will normally invest in all of the securities comprising the Index in proportion to their weightings in the Index. The Index is determined, composed and calculated by Bloomberg Index Services Limited (BISL or the Index Provider). The Index Provider reserves the right to make exceptions when applying the methodology if the need arises to ensure that the Index continues to achieve its objective. In addition, the Index Provider may revise Index policy covering rules for selecting companies, treatment of dividends, share counts or other matters. First Trust Advisors L.P., the Fund's investment advisor, maintains no discretion with regard to the compilation and composition of the Index or any changes thereto.

Yum Brands Inc.

Apple Inc

Nvidia Corp.United States -Information Technology

Ford Motor Credit

Broadcom Inc

Oracle Ord

Mastercard Inc

Intl. Bus. Machines Corp.

Walt Disney Co

AT&T Inc.

Chevron Corp

General Motors Company, Long Equties

Spotify Technology SA

Eli Lilly And Company

First Trust New Constructs Core Earnings Leaders ETF

Trading Ideas

JMIA

Jumia Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Up 17.2%

WIIM

Nike shares are trading higher after Argus Research analyst John Staszak upgraded the stock from Hold to Buy.

Wells Fargo analyst Joseph O'Dea maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Overweight and raises the price target from $315 to $365.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Rockwell Automation, Raises Price Target to $365

Argus Research analyst John Staszak upgrades Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) from Hold to Buy.

Upgrades

SOLV

Argus Research Upgrades Solventum to Buy

Wells Fargo analyst Joseph O'Dea maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Overweight and raises the price target from $670 to $770.

Wells Fargo Maintains Overweight on Parker Hannifin, Raises Price Target to $770

<a href="https://www.youtube.com/watch?v=L6rcfh4Q-rk">https://www.youtube.com/watch?v=L6rcfh4Q-rk</a>

Macro Notification

Politics

Economics

General

Fed Chair Powell Says Debt Path Not Sustainable, Will Have To Be Addressed Sooner Or Later

<a href="https://www.bloomberg.com/news/videos/2025-06-30/tiktok-buyer-has-been-found-says-trump-video" title="https://www.bloomberg.com/news/videos/2025-06-30/tiktok-buyer-has-been-found-says-trump-video">https://www.bloomberg.com/news/videos/2025-06-30/tiktok-buyer-has-been-found-says-trump-video</a>
&nbsp;

ORCL

SNAP

Reported June 30, 2025: 'President Donald Trump Says A Buyer Group For TikTok Has Been Found And A Nod From China Is Now Needed' - Bloomberg News

Wells Fargo analyst Joseph O'Dea maintains Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) with a Equal-Weight and raises the price target from $95 to $100.

OTIS

Wells Fargo Maintains Equal-Weight on Otis Worldwide, Raises Price Target to $100

Goldman Sachs analyst Stephen Laszczyk upgrades Hasbro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) from Neutral to Buy and raises the price target from $66 to $85.

Goldman Sachs Upgrades Hasbro to Buy, Raises Price Target to $85

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01085152/Chaoju-0701-900x600-1.png" alt="" class="wp-image-15130" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01085152/Chaoju-0701-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01085152/Chaoju-0701-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01085152/Chaoju-0701-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The private hospital and clinic operator announced two new purchases, signaling a potential return to acquisitions after a quiet period last year
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Chaoju Eye Care announced plans to buy out one of its majority-owned eye care facilities in Ningbo, and purchase 70% of another facility in the Ningxia region</li>
<li>The company is trying to jumpstart its growth, as its revenue began to contract and its profit tumbled 30% in the second half of last year</li>
</ul>
It ain't easy being outside the Chinese national health system.
That's a lesson that many operators of the thousands of private hospitals and clinics outside China's national health plan have been learning lately, as they try to make money by providing elective services such as eye and dental care, and cosmetic surgery. But in a slowing economy like the current one, consumers are reining in their spending on such elective procedures that aren't covered by China's national medical insurance.
As their businesses stagnate and even start to contract, some companies are trying to bring excitement back to their stagnating stocks by growth through acquisitions. One of those is&nbsp;Chaoju Eye Care Holdings Ltd.&nbsp;(2219.HK), which on Monday&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0630/2025063004076.pdf">announced</a>&nbsp;plans to acquire two hospitals, one in the coastal city of Ningbo in East China's Zhejiang province, and the other in the city of Wuzhong in the less developed Ningxia region in interior China.
Both acquisitions look aimed at getting investors interested in Chaoju, which hoped to position itself as a consolidator in China's fragmented eye care industry at the time of its IPO back in 2021. Neither of these two deals looks all that exciting, for reasons we'll explain shortly. But on a more symbolic level, they could indicate that Chaoju is back in acquisition mode after going more than a year without any major new purchases.
Perhaps reflecting how difficult it is to run such centers profitably, Chaoju isn't paying all that much for the two facilities in its latest announcement. The larger of the deals will see Chaoju pay about 14 million yuan ($2 million) for 37% Ningbo Boshi Eye Hospital, valuing the facility at about 38 million yuan.
Here, we should point out that Chaoju already owned the other 63% of Boshi Eye Hospital, so it was already the facility's majority shareholder and consolidated the hospital's results into its financial reports. So, this particular deal isn't even really an acquisition.
The second deal is an actual acquisition that will see Chaoju buy 70% of Wuzhong Yunshikang Eye Hospital for about 5 million yuan. That modest price values the hospital at just 7.14 million yuan, or around $1 million, which is hardly a mega-deal.
"These acquisitions form part of the company's established strategic plan," Chaoju said. "The company will continue to deepen its presence in the Zhejiang and Ningxia regions, strengthen its industry competitiveness through multi-point deployment, expand its market share, and effectively mitigate market risks."
Chaoju announced the deals ahead of a Hong Kong public holiday on July 1, so we won't get to see what shareholders thought until trading resumes on Wednesday. But we wouldn't be surprised to see little or no reaction, since the combined deals are only worth 20 million yuan, or less than $3 million.
<h4 class="wp-block-heading">Lack of excitement</h4>
Such a muted reaction would mirror Chaoju's broader recent performance, with the shares unchanged from where they started the year. Based in interior China's Inner Mongolia region, the company looked more interesting at the time of its 2021 IPO due to its potential to help consolidate an industry set for strong growth. But since then it has largely disappointed, and the latest close of HK$2.85 for its stock is down more than 70% from its IPO price of HK$10.60.
Chaoju certainly isn't alone in being shunned by investors, who are rapidly losing interest in such private hospital and clinic operators. The company's current price-to-earnings (P/E) ratio of 9.2 looks quite low compared to other healthcare tickers from the drug and medical device sector. But it's quite similar to the 9.9 ratio of&nbsp;Modern Dental&nbsp;(3600.HK), an operator of private dental clinics, as well as the 10 for&nbsp;Perfect Medical&nbsp;(1830.HK), which owns a chain of cosmetic surgery centers.
Chaoju looked a bit more interesting shortly after its IPO, when it embarked on a relatively aggressive buying spree as it moved beyond its home base in Inner Mongolia. The company operated 17 eye hospitals and 24 optical centers at the end of 2021, shortly after its listing, and had boosted that network with nine additions in 2022, including seven hospitals and two optical centers.
It continued that pace of expansion in 2023 with 10 additions, seven hospitals and three optical centers, bringing its network to 31 hospitals and 29 optical centers by the end of that year. But then its expansion suddenly came to a halt, with no new additions last year. The company announced plans to buy a Beijing hospital at the start of 2024, which would have been a relatively large purchase costing 36.8 million yuan. But that deal, involving the Beijing Mingyue Ophthalmic Clinic, apparently never closed, as the hospital wasn't included in the company's latest annual report released in April this year.
As its growth via acquisitions has stalled, Chaoju has also started feeling the effects of China's economic slowdown. The company managed to eke out 2.6% revenue growth last year, as the figure reached 1.41 billion yuan. But calculations using the annual report and data for the first half of last year showed Chaoju's revenue began to contract in the second half of last year, falling 0.9%, after growing 6% in the first half.
The company's gross margin last year also fell by nearly 2 percentage points to 43.5% from 45.4% in 2023, reflecting shrinking profitability as patient numbers and average spending per customer came under pressure, even as its operating costs remained relatively unchanged.
As a result of that, its profit for all 2024 fell 12% to 186 million yuan from 221 million yuan a year earlier. And some calculations show that its profit fell by a far larger 30% year-on-year in the second half of 2024, compared with an 8.8% decline in the first half of the year.
Chaoju certainly has plenty of money for future acquisitions, reporting 781 million yuan in its coffers at the end of last year, up sharply from 463 million yuan a year earlier. The latest announcement could signal it's preparing to use more of that cash to start making more acquisitions again. That could bring some excitement back to its stock if it finds good acquisition targets, though it will need to be careful to avoid assets whose financial positions may be shaky in the currently weak economic environment.

Asia

Equities

Global

Opinion

It Isn't Easy Being Outside The Chinese National Health System: The Story Of Chaoju Eye Care

Wells Fargo analyst Joseph O'Dea maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Underweight and raises the price target from $500 to $550.

Wells Fargo Maintains Underweight on Lennox Intl, Raises Price Target to $550

Goldman Sachs analyst Neil Mehta downgrades Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) from Buy to Neutral and maintains the price target from $31 to $31.

Downgrades

CTRA

Goldman Sachs Downgrades Coterra Energy to Neutral, Maintains Price Target to $31

Argus Research analyst John Staszak upgrades Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Hold to Buy and maintains the price target from $85 to $85.

Argus Research Upgrades Nike to Buy, Maintains Price Target to $85

Wells Fargo analyst Joseph O'Dea maintains Ingersoll Rand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IR#NYSE">IR</a>) with a Overweight and raises the price target from $86 to $95.

Wells Fargo Maintains Overweight on Ingersoll Rand, Raises Price Target to $95

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) has outperformed the market over the past 20 years by 13.81% on an annualized basis producing an average annual return of 22.29%. Currently, Salesforce has a market capitalization of $260.65 billion. 
Buying $1000 In CRM: If an investor had bought $1000 of CRM stock 20 years ago, it would be worth $56,075.06 today based on a price of $272.65 for CRM at the time of writing.
<h3>Salesforce's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751379365_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Salesforce 20 Years Ago Would Be Worth This Much Today

Artificial intelligence is taking over tax preparation at major brokerage houses, easing the burden on small and large investors. That means less time poring through spreadsheets, looking to save pennies, and more time growing long-term assets.&nbsp;
Traditionally, investors <a href="https://www.kiplinger.com/taxes/tax-planning/technology-unleashes-power-of-year-round-tax-loss-harvesting">calculated</a> the tax impact of trading losses once per year because it was so complex, often requiring extensive record-keeping. That meant waiting until the fourth quarter, or until brokers mailed a list of transactions in January on IRS Form 1099. Thankfully, high tech has now taken the wheel, according to Kiplinger, with automated tax-loss harvesting doing the math work.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
Federal rules allow investors who lose money on certain securities to deduct part of their losses from taxable income. Most of these calculations come into play with stocks, but index funds, bonds, <a href="https://www.rentastic.io/blog/capital-gains-tax-loss-harvesting#:~:text=Capital%20Gains%20Tax%20Overview,year%20(The%20Tax%20Adviser).&amp;text=Hits%20like%20regular%20income%20taxes,40.8%25%20for%20the%20big%20earners.&amp;text=More%20like%20a%20%22nice%20to,%25%20for%20the%20well%2Doff.&amp;text=Knock%20down%20both%20short%2D%252">real estate</a> and even cryptocurrency can meet loss requirements. Instead of doing-it-yourself, automated tax-loss harvesting can now match up those gains and losses daily.&nbsp;
Note: traditional 401(k) retirement accounts can't harvest losses because they are not taxed until distribution.&nbsp;
Automated harvesting is generally free for small investors through popular <a href="https://www.schwab.com/automated-investing/what-is-a-robo-advisor">robo-advisors</a>, requiring just a quick opt-in. According to Kiplinger, the AI harvests when an investor sells assets, including stocks, that have lost value and uses the proceeds to offset gains from other assets. However, these transactions can conflict with the equally arcane wash sale rule, which may change official entry and exit prices of affected instruments.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
<a href="https://www.benzinga.com/quote/JPM">JPMorgan Chase</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) <a href="https://www.chase.com/personal/investments/learning-and-insights/article/what-is-a-wash-sale-things-to-know#:~:text=The%20wash%2Dsale%20rule%20prevents,tax%20benefits%20of%20realizing%20losses.">explains</a> the wash sale rule, which triggers when you sell a security at a loss and buy a "substantially identical" security within 30 days. IRS created this market prohibition to "prevent taxpayers from deducting paper losses without significantly changing their market position." Harvesting AI solves this issue by considering wash sales when matching up transactions used to reduce capital gains and/or increase capital losses.
Extensive back-end record-keeping is needed for daily tax-loss harvesting. Kiplinger notes the complexity of this task, citing an example in which a portfolio has 15 securities, each with 15 tax lots, or groupings with the same entry price and time stamp. That equals 225 total lots needing review before any harvesting. Now, imagine how many terabytes are required to examine the thousands of trades done each year by some short-term players.
Harvesting and other broker tech now examine enormous records and match them daily. This adds to an automation trend that started in <a href="https://help.streetsmart.schwab.com/edge/1.6/Content/wash_sale.htm#:~:text=A%20Wash%20Sale%20occurs%20when,the%20loss%20can%20be%20taken.">2011</a> when the IRS required brokers to recalculate the security's cost basis in real time to account for wash sales. This is why some investors still scratch their heads, trying to figure out why the prices and profits reported on monthly statements don't match their transactions.
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<a href="https://www.kiplinger.com/retirement/how-direct-indexing-can-be-a-smarter-way-to-invest">Direct index</a> strategies have multiplied like rabbits since automated tax-loss harvesting came into popular use. In this scheme, large investors buy stocks of an index directly, and in proportion to the underlying <a href="https://www.benzinga.com/money/equal-weight-etfs">weighting</a>. Harvesting then consumes orders of magnitude more data than Kiplinger's example, capturing losses up to 40% of the portfolio, or "nearly double" common ETF-to-ETF trading strategies.
Despite its promise, the benefits of this artificial intelligence are negligible if small investors don't actively buy and sell stocks. As Kitces.com columnist Ben Hendry-Moreland <a href="https://www.kitces.com/blog/automated-tax-loss-harvesting-technology-software-value-risks-gaps-benefits/">notes</a>, much of this technology "fails to consider the individual tax circumstances." And he admits that, "in reality, not all investors may benefit from tax-loss harvesting."
Read Next: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
Image: Shutterstock

Personal Finance

This Tech Upgrade Could Save Investors Thousands in Taxes—Automatically

Fed Chair Powell Says Nothing Has Changed With Regard To Swap Lines

Goldman Sachs analyst Neil Mehta upgrades Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) from Neutral to Buy and raises the price target from $47 to $51.

Goldman Sachs Upgrades Ovintiv to Buy, Raises Price Target to $51

Evercore ISI Group analyst Duane Pfennigwerth upgrades Allegiant Travel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGT#NASDAQ">ALGT</a>) from In-Line to Outperform and announces $75 price target.

ALGT

Evercore ISI Group Upgrades Allegiant Travel to Outperform, Announces $75 Price Target

INACU

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Press Releases

First Trust Launches First Trust New Constructs Core Earnings Leaders ETF

FTCE

Comments

First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF

Intérêt court

First Trust Exchange-Traded Fund VI First Trust New Constructs Core Earnings Leaders ETF (ARCA:FTCE), Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL